Analystreport

"Denali Therapeutics Inc." (NASDAQ: DNLI) is now covered by analysts at Goldman Sachs Group Inc. They set a "neutral" rating on the stock.

Denali Therapeutics Inc.  (DNLI) 
Last denali therapeutics inc. earnings: 8/6 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.denalitherapeutics.com